Loading…

β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals

β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA...

Full description

Saved in:
Bibliographic Details
Published in:Microbiology and immunology 2021-09, Vol.65 (9), p.343-351
Main Authors: Dewake, Nanae, Ma, Xiangtao, Sato, Kayo, Nakatsu, Susumu, Yoshimura, Kenji, Eshita, Yoshiyuki, Fujinaka, Hidetake, Yano, Yoshitaka, Yoshinari, Nobuo, Yoshida, Akihiro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413
cites cdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413
container_end_page 351
container_issue 9
container_start_page 343
container_title Microbiology and immunology
container_volume 65
creator Dewake, Nanae
Ma, Xiangtao
Sato, Kayo
Nakatsu, Susumu
Yoshimura, Kenji
Eshita, Yoshiyuki
Fujinaka, Hidetake
Yano, Yoshitaka
Yoshinari, Nobuo
Yoshida, Akihiro
description β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.
doi_str_mv 10.1111/1348-0421.12884
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2514603588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2570164057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</originalsourceid><addsrcrecordid>eNqFkbFu2zAURYmiQeOknbMFBLJ0kUOKpESPgdE6BmxkaWfikaJsBpLokFIMbf2Efks_pB_RLwkdJxmy9C0XeDjv4uFehC4omdI015RxmRGe0ynNpeQf0ORt8xFNCJMiEwUhp-gsxntC8jKX_BM6ZUwWRBRsgvzfP_9-_V40oxlD2Nredc5gMK7Crts67fqI-63FGkxvg4MGb4Lf91sMXYW187VrWlz70ELvfIf1iOOwC7Bx3cY9JnrXwMNgsfFta7sITfyMTuok9suLnqOf37_9mN9mq7vFcn6zygxnBc9yKg0BgBljdSUYNTNelTOQVIMlUBpZM11JYXUxY0ZWXLOalILQ2lDQhlN2jr4efXfBpw9ir1oXjW0a6KwfosoF5QVhQsqEXr1D7_0QuvRdokpCC05EmajrI2WCjzHYWu2CayGMihJ16EIdkleH5NVzF-ni8sV30K2t3vjX8BMgjsDeNXb8n59aL9dH4yfyW5aR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570164057</pqid></control><display><type>article</type><title>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</title><source>Wiley</source><source>Alma/SFX Local Collection</source><creator>Dewake, Nanae ; Ma, Xiangtao ; Sato, Kayo ; Nakatsu, Susumu ; Yoshimura, Kenji ; Eshita, Yoshiyuki ; Fujinaka, Hidetake ; Yano, Yoshitaka ; Yoshinari, Nobuo ; Yoshida, Akihiro</creator><creatorcontrib>Dewake, Nanae ; Ma, Xiangtao ; Sato, Kayo ; Nakatsu, Susumu ; Yoshimura, Kenji ; Eshita, Yoshiyuki ; Fujinaka, Hidetake ; Yano, Yoshitaka ; Yoshinari, Nobuo ; Yoshida, Akihiro</creatorcontrib><description>β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.</description><identifier>ISSN: 0385-5600</identifier><identifier>EISSN: 1348-0421</identifier><identifier>DOI: 10.1111/1348-0421.12884</identifier><identifier>PMID: 33860563</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Antibacterial activity ; Antibacterial agents ; Bacteria ; biofilm ; Biofilms ; coaggregation ; Commensals ; gingivitis ; Minimum inhibitory concentration ; Periodontal diseases ; supragingival plaque ; β‐glycyrrhetinic acid (BGA)</subject><ispartof>Microbiology and immunology, 2021-09, Vol.65 (9), p.343-351</ispartof><rights>2021 The Societies and John Wiley &amp; Sons Australia, Ltd.</rights><rights>This article is protected by copyright. All rights reserved.</rights><rights>2021 The Societies and John Wiley &amp; Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</citedby><cites>FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</cites><orcidid>0000-0003-1296-9022</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33860563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dewake, Nanae</creatorcontrib><creatorcontrib>Ma, Xiangtao</creatorcontrib><creatorcontrib>Sato, Kayo</creatorcontrib><creatorcontrib>Nakatsu, Susumu</creatorcontrib><creatorcontrib>Yoshimura, Kenji</creatorcontrib><creatorcontrib>Eshita, Yoshiyuki</creatorcontrib><creatorcontrib>Fujinaka, Hidetake</creatorcontrib><creatorcontrib>Yano, Yoshitaka</creatorcontrib><creatorcontrib>Yoshinari, Nobuo</creatorcontrib><creatorcontrib>Yoshida, Akihiro</creatorcontrib><title>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</title><title>Microbiology and immunology</title><addtitle>Microbiol Immunol</addtitle><description>β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.</description><subject>Antibacterial activity</subject><subject>Antibacterial agents</subject><subject>Bacteria</subject><subject>biofilm</subject><subject>Biofilms</subject><subject>coaggregation</subject><subject>Commensals</subject><subject>gingivitis</subject><subject>Minimum inhibitory concentration</subject><subject>Periodontal diseases</subject><subject>supragingival plaque</subject><subject>β‐glycyrrhetinic acid (BGA)</subject><issn>0385-5600</issn><issn>1348-0421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkbFu2zAURYmiQeOknbMFBLJ0kUOKpESPgdE6BmxkaWfikaJsBpLokFIMbf2Efks_pB_RLwkdJxmy9C0XeDjv4uFehC4omdI015RxmRGe0ynNpeQf0ORt8xFNCJMiEwUhp-gsxntC8jKX_BM6ZUwWRBRsgvzfP_9-_V40oxlD2Nredc5gMK7Crts67fqI-63FGkxvg4MGb4Lf91sMXYW187VrWlz70ELvfIf1iOOwC7Bx3cY9JnrXwMNgsfFta7sITfyMTuok9suLnqOf37_9mN9mq7vFcn6zygxnBc9yKg0BgBljdSUYNTNelTOQVIMlUBpZM11JYXUxY0ZWXLOalILQ2lDQhlN2jr4efXfBpw9ir1oXjW0a6KwfosoF5QVhQsqEXr1D7_0QuvRdokpCC05EmajrI2WCjzHYWu2CayGMihJ16EIdkleH5NVzF-ni8sV30K2t3vjX8BMgjsDeNXb8n59aL9dH4yfyW5aR</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Dewake, Nanae</creator><creator>Ma, Xiangtao</creator><creator>Sato, Kayo</creator><creator>Nakatsu, Susumu</creator><creator>Yoshimura, Kenji</creator><creator>Eshita, Yoshiyuki</creator><creator>Fujinaka, Hidetake</creator><creator>Yano, Yoshitaka</creator><creator>Yoshinari, Nobuo</creator><creator>Yoshida, Akihiro</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1296-9022</orcidid></search><sort><creationdate>202109</creationdate><title>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</title><author>Dewake, Nanae ; Ma, Xiangtao ; Sato, Kayo ; Nakatsu, Susumu ; Yoshimura, Kenji ; Eshita, Yoshiyuki ; Fujinaka, Hidetake ; Yano, Yoshitaka ; Yoshinari, Nobuo ; Yoshida, Akihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibacterial activity</topic><topic>Antibacterial agents</topic><topic>Bacteria</topic><topic>biofilm</topic><topic>Biofilms</topic><topic>coaggregation</topic><topic>Commensals</topic><topic>gingivitis</topic><topic>Minimum inhibitory concentration</topic><topic>Periodontal diseases</topic><topic>supragingival plaque</topic><topic>β‐glycyrrhetinic acid (BGA)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dewake, Nanae</creatorcontrib><creatorcontrib>Ma, Xiangtao</creatorcontrib><creatorcontrib>Sato, Kayo</creatorcontrib><creatorcontrib>Nakatsu, Susumu</creatorcontrib><creatorcontrib>Yoshimura, Kenji</creatorcontrib><creatorcontrib>Eshita, Yoshiyuki</creatorcontrib><creatorcontrib>Fujinaka, Hidetake</creatorcontrib><creatorcontrib>Yano, Yoshitaka</creatorcontrib><creatorcontrib>Yoshinari, Nobuo</creatorcontrib><creatorcontrib>Yoshida, Akihiro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Microbiology and immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dewake, Nanae</au><au>Ma, Xiangtao</au><au>Sato, Kayo</au><au>Nakatsu, Susumu</au><au>Yoshimura, Kenji</au><au>Eshita, Yoshiyuki</au><au>Fujinaka, Hidetake</au><au>Yano, Yoshitaka</au><au>Yoshinari, Nobuo</au><au>Yoshida, Akihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</atitle><jtitle>Microbiology and immunology</jtitle><addtitle>Microbiol Immunol</addtitle><date>2021-09</date><risdate>2021</risdate><volume>65</volume><issue>9</issue><spage>343</spage><epage>351</epage><pages>343-351</pages><issn>0385-5600</issn><eissn>1348-0421</eissn><abstract>β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33860563</pmid><doi>10.1111/1348-0421.12884</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-1296-9022</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0385-5600
ispartof Microbiology and immunology, 2021-09, Vol.65 (9), p.343-351
issn 0385-5600
1348-0421
language eng
recordid cdi_proquest_miscellaneous_2514603588
source Wiley; Alma/SFX Local Collection
subjects Antibacterial activity
Antibacterial agents
Bacteria
biofilm
Biofilms
coaggregation
Commensals
gingivitis
Minimum inhibitory concentration
Periodontal diseases
supragingival plaque
β‐glycyrrhetinic acid (BGA)
title β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A44%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2%E2%80%90Glycyrrhetinic%20acid%20inhibits%20the%20bacterial%20growth%20and%20biofilm%20formation%20by%20supragingival%20plaque%20commensals&rft.jtitle=Microbiology%20and%20immunology&rft.au=Dewake,%20Nanae&rft.date=2021-09&rft.volume=65&rft.issue=9&rft.spage=343&rft.epage=351&rft.pages=343-351&rft.issn=0385-5600&rft.eissn=1348-0421&rft_id=info:doi/10.1111/1348-0421.12884&rft_dat=%3Cproquest_cross%3E2570164057%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2570164057&rft_id=info:pmid/33860563&rfr_iscdi=true